Dorothy Grange, MD
Clinical Genetics (M.D.) · Saint Louis, MONPI 1801812128
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Biomarin Pharmaceutical Inc. accounts for 67.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $635, 3.5 times the $179 reported in 2019.
Across 20 payments — averaging $93.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$1K
- Amgen$237
- Sanofi$175
- Mirum Pharmaceuticals, Inc.$102
- PTC Therapeutics, Inc.$60
- Ultragenyx Pharmaceutical Inc.$30
Across 161 payments — averaging $4349.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$327K
- Biomarin Pharmaceutical Inc.$236K
- Shire North American Group Inc$77K
- Sanofi US Services Inc.$62K
What the payments were for
- Food & beverage$1,83998%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 12 | $1,265 |
| Amgen | 3 | $237 |
| Sanofi | 2 | $175 |
| Mirum Pharmaceuticals, Inc. | 1 | $102 |
| PTC Therapeutics, Inc. | 1 | $60 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RavictiGlycerol Phenylbutyrate | 15 | $1,882,124 |
| PalynziqPegvaliase-Pqpz | 12 | $192,217 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenRavicti | $237 | $1,882,12415 claims |
| Biomarin Pharmaceutical Inc.Palynziq | $1,265 | $192,21712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical genetics (m.d.) providers in Missourion file to place this against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Saint Louis
- Gary GottesmanSaint Louis$28K
- Patricia DicksonSaint Louis$4K
- Hoanh NguyenSaint Louis$1K
- Maria Duque LasioSaint Louis$787
- Marwan ShinawiSaint Louis$229
- Katherine KingSaint Louis$63
- Diana GraySaint Louis$20
- Eric RushKansas City$779K
- Majed DasoukiKansas City$2K
- Angela LeeKansas City$490
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.